Launching a new drug is a complex process. Launching orphan drugs in a new or existing market adds...

Stay up to date with the latest news from Techspert, and read updates and insights from the many industries we work in
Techspert's recognition as the 539th placement in the Financial Times 1000: Europe’s Fastest Growing Companies underscores our commitment to revolutionizing how expert insights are accessed and applied in the healthcare and life sciences sectors....
Read moreLaunching a new drug is a complex process. Launching orphan drugs in a new or existing market adds...
Ayaka Shinozaki, a machine learning engineer at Techspert – the AI technology innovator...
In this series of expert interviews, Techspert speaks with frontline healthcare specialists to get...
Following the tragic death of George Floyd, like many people and organizations, we’ve been...
Among many other things, the rapid spread of coronavirus has highlighted the importance of access...
Techspert, AI technology innovator specializing in connecting businesses directly to experts for...